Yi-Shiou Chiou 1,5, Shengmin Sang 2, Kuang-Hung Cheng 3, Chi-Tang Ho 4, Ying-Jan Wang 5 and Min-Hsiung Pan 1, *

Size: px
Start display at page:

Download "Yi-Shiou Chiou 1,5, Shengmin Sang 2, Kuang-Hung Cheng 3, Chi-Tang Ho 4, Ying-Jan Wang 5 and Min-Hsiung Pan 1, *"

Transcription

1 Carcinogenesis vol.34 no.6 pp , 2013 doi: /carcin/bgt042 Advance Access publication February 5, 2013 Peracetylated ( )-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34 + skin stem cells and skin tumors Yi-Shiou Chiou 1,5, Shengmin Sang 2, Kuang-Hung Cheng 3, Chi-Tang Ho 4, Ying-Jan Wang 5 and Min-Hsiung Pan 1, * 1 Department of Seafood Science, National Kaohsiung Marine University, Kaohsiung 811, Taiwan, 2 Center for Excellence in Post-Harvest Technologies, North Carolina Agricultural and Technical State University, North Carolina Research Campus, 500 Laureate Way, Kannapolis, NC 28081, USA, 3 Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan, 4 Department of Food Science, Rutgers University, New Brunswick, NJ , USA and 5 Department of Environmental and Occupational Health, National Cheng Kung University Medical College, Tainan 704, Taiwan *To whom correspondence should be addressed. Department of Seafood Science, National Kaohsiung Marine University, No. 142, Hai-Chuan Rd, Nan-Tzu, Kaohsiung, Taiwan. Tel: ; Fax: ; mhpan@mail.nkmu.edu.tw Correspondence may also be addressed to Ying-Jan Wang. Department of Environmental and Occupational Health, National Cheng Kung University Medical College, 138 Sheng-Li Road, Tainan 70428, Taiwan. Tel: ext. 5804; Fax: ; yjwang@mail.ncku.edu.tw During the process of skin tumor promotion, expression of the cutaneous cancer stem cell (CSC) marker CD34 + is required for stem cell activation and tumor formation. A previous study has shown that activation of protein kinase D1 (PKD1) is involved in epidermal tumor promotion; however, the signals that regulate CSCs in skin carcinogenesis have not been characterized. This study was designed to investigate the chemopreventive potential of peracetylated ( )-epigallocatechin-3-gallate (AcEGCG) on 7,12-dimethylbenz[a]-anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin tumorigenesis in ICR mice and to elucidate the possible mechanisms involved in the inhibitory action of PKD1 on CSCs. We demonstrated that topical application of AcEGCG before TPA treatment can be more effective than EGCG in reducing DMBA/TPA-induced tumor incidence and multiplicity. Notably, AcEGCG not only inhibited the expression of p53, p21, c-myc, cyclin B, p-cdk1 and Cdc25A but also restored the activation of extracellular signal-regulated kinase 1/2 (ERK1/2), which decreased DMBA/TPA-induced increases in tumor proliferation and mitotic index. To clarify the role of PKD1 in cell proliferation and tumorigenesis, we studied the expression and activation of PKD1 in CD34 + skin stem cells and skin tumors. We found that PKD1 was strongly expressed in CD34 + cells and that pretreatment with AcEGCG markedly inhibited PKD1 activation and CD34 + expression. More importantly, pretreatment with AcEGCG remarkably suppressed nuclear factor-kappab, cyclic adenosine 3,5 -monophosphate-responsive element-binding protein (CREB) and CCAAT-enhancer-binding protein (C/EBPs) activation by inhibiting the phosphorylation of c-jun-n-terminal kinase 1/2, p38 and phosphatidylinositol 3-kinase (PI3K)/Akt and by attenuating downstream target gene expression, including inducible nitric oxide synthase, cyclooxygenase-2, ornithine Abbreviations: AcEGCG, peracetylated ( )-epigallocatechin-3-gallate; COX-2, cyclooxygenase-2; CREB, camp-responsive element-binding protein; CSC, cancer stem cell; DMBA, 7,12-dimethylbenz[a]anthracene; EBP, enhancer-binding protein; EGCG, epigallocatechin-3-gallate; ERK, extracellular signal-regulated kinase; H&E, hematoxylin and eosin; inos, inducible nitric oxide synthase; IκB, inhibitor κb; NF-κB, nuclear factor-κb; ODC, ornithine decarboxylase; PI3K, phosphatidylinositol 3-kinase; PKD1, protein kinase D-1; TPA, 12-O-tetradecanoylphorbol-13-acetate; VEGF, vascular endothelial growth factor. decarboxylase and vascular endothelial growth factor. Moreover, this is the first study to demonstrate that AcEGCG is a CD34 + and PKD1 inhibitor in the multistage mouse skin carcinogenesis model. Overall, our results powerfully suggest that AcEGCG could be developed into a novel chemopreventive agent and that PKD1 may be a preventive and therapeutic target for skin cancer in clinical settings. Introduction The incidence of skin cancer is rising steadily and presents a growing health problem. The development of skin cancer is a multistage process including initiation, promotion and progression. The functions of cancer stem cells (CSCs) and keratinocyte stem cells play critical roles during the process of skin carcinogenesis (1). Recent evidence suggests that the cell surface glycoprotein, CD34 +, a stem and progenitor cell marker, is expressed in tumor epithelial cells and is required for skin tumor development in mice (2). In addition to CD34, PKD1 (protein kinase D1) also plays an important role in keratinocyte functions that regulate proliferative and antidifferentiative processes (3). Similarly, Ristich et al. (4) found that aberrant distribution and upregulation of PKD1 are associated with neoplastic mouse keratinocyte and basal cell carcinoma development, suggesting a putative tumorigenic role for PKD1 in the skin. The PKD1 gene is a novel serine/threonine kinase originally categorized as a member of the protein kinase C (PKC) family (and designated PKCμ) because of its two cysteine-rich domains that bind diacylglycerol and phorbol esters (5). Since its discovery, PKD1 has been shown to interact with and modulate the functions of proteins implicated in variety of signaling pathways, including proliferation, survival, apoptosis, angiogenesis and motility (6). Although PKD1 is known to regulate skin tumor promotion, its role in regulating cancer stemness and the resulting skin tumor progression remains unknown. In this study, we sought to identify the expression machinery critical for PKD1 activation and skin CSC proliferation. The two-stage model of mouse skin carcinogenesis has been used for studying mechanisms of chemical carcinogenesis and evaluating novel skin cancer prevention strategies. In the mouse model of skin cancer, tumor initiation can be induced by a single topical application of 7,12-dimethylbenz[a]-anthracene (DMBA), a mutagenic chemical initiator that acts on the H-Ras proto-oncogene. Tumor promotion follows and is produced by the repeated application of 12-O-tetradecanoylphorbol-13-acetate (TPA), a tumor promoter that leads to tumor development (7). In this model, all of the stages of carcinogenesis can be targeted for chemopreventive intervention (8). Epidemiological and clinical studies have suggested that the consumption of green tea lowers the risk of cancer. ( )-Epicatechin- 3-gallate (EGCG), the major natural polyphenolic compound in green tea, exhibits skin cancer-preventive activity in various in vitro and in vivo models (9). However, EGCG is hydrophilic and exhibits poor cellular absorption, low bioavailability and low stability, which lead to a reduction in its cancer-preventive activity. To increase the lipophilicity and membrane permeability and improve the bioefficacy of EGCG, peracetylated EGCG (AcEGCG) was synthesized (10). Previous studies have demonstrated that AcEGCG acts as a prodrug of EGCG with greater potency than EGCG in the inhibition of proteasome activity, tumor proliferation and inflammation. In addition, AcEGCG has been shown to induce apoptosis in vitro and in vivo (11 13). Studies from our laboratory have demonstrated that AcEGCG is more potent than EGCG for the treatment of colitis-induced colon carcinogenesis The Author Published by Oxford University Press. All rights reserved. For Permissions, please journals.permissions@oup.com 1315

2 Y-S.Chiou et al. (14). However, the specific regulatory mechanisms of AcEGCG at the level of target proteins (CD34 or PKD1) are not known for the skin carcinogenesis process. In this research, we compared the effects of EGCG and AcEGCG on DMBA/TPA-mediated skin tumorigenesis and explored the underlying molecular mechanisms of signaling. We examined whether AcEGCG can be used as a non-selective PKD1 and CD34 inhibitor and also investigated the role of PKD1 in proliferative CD34-expressing CSCs. In summary, our results reveal for the first time that AcEGCG is a more potent chemopreventive agent than EGCG for the prevention of DMBA/TPA-induced skin carcinogenesis. This activity appears to be mediated through a blockade of nuclear factor-κb (NF-κB), CCAATenhancer-binding protein β and δ (C/EBPβ and C/EBPδ) activation via the downregulation of PKD1 signaling, as well as several downstream targets, including c-jun-n-terminal kinase 1/2, p38, PI3K/Akt and cell cycle-regulated signaling pathways. To our knowledge, this is the first study to show that PKD1 is a novel regulator in cutaneous CD34 + CSCs during DMBA/TPA-mediated tumorigenesis. Further understanding of the role of PKD1 may contribute to new preventive and therapeutic strategies in inflammation-related tumorigenesis. Materials and methods Reagents and antibodies TPA and DMBA were purchased from Sigma Chemical Co. (St Louis, MO). EGCG (100% pure) was isolated from a crude green tea polyphenol extract and provided by Dr Chi-Tang Ho (Department of Food Science, Rutgers University). AcEGCG was provided by Dr Shengmin Sang (North Carolina Agricultural and Technical State University). Briefly, AcEGCG was synthesized using a pyridine catalyzed reaction of EGCG with acetic anhydride (15). Antibodies against inos, IκBα, p-iκbα, p65, p50, vascular endothelial growth factor (VEGF), MMP-9, C/EBPβ, C/EBPδ, phospho-pi3k (Tyr508) and β-actin were purchased from Santa Cruz Biotechnology, CA. Anti-COX-2 and ornithine decarboxylase (ODC) monoclonal antibodies were purchased from BD Transduction Laboratories, Lexington, KY, Taiwan. Phospho-p65 (Ser536), p-erk1/2 (Thr202/Tyr204), p-p38 (Thr180/Tyr182), p-jnk1/2 (Thr183/Tyr185), ERK, JNK1/2, p38, p-pkd1 (Ser916 and 744/748), P53, P21, c-myc, cyclin B, CDK-1, cdc25a and PKD1 were purchased from Cell Signaling Technology, Beverly, MA. p-iκbα (Ser32/Ser36), p-akt (Ser473) and Akt polyclonal antibodies were purchased from Upstate Biotechnology, Lake Placid, NY. CD34 and PKD1 polyclonal antibodies were purchased from Bioss. Animals care and two-stage tumorigenesis in mouse skin Male ICR mice at 6 weeks of age were purchased from the BioLASCO Experimental Animal Center (Taiwan Co., Ltd). After 1 week of acclimation, animals were randomly distributed into control and experimental groups. All animals were housed in a controlled atmosphere (25 ± 1 C at 50% relative humidity) under a 12 h light/12 h dark cycle. Animals had free access to food and water at all times. Food cups were replenished with fresh diet every day. All animal experimental protocol used in this study was approved by Institutional Animal Care and Use Committee of the National Kaohsiung Marine University (IAC UC, NKMU). One group was composed of 12 female ICR mice. These mice were given commercial rodent pellets and fresh tap water ad libitum, both of which were changed twice a week. The dorsal region of each mouse was shaved with an electric clipper 2 days before initiation. Mice at 6 weeks old were started on 200 nm DMBA in 200 μl acetone (Ac) and control mice received 200 μl acetone alone. One week after initiation, the mice were topically treated with 200 μl acetone or promoted with TPA (5 nm in 200 μl acetone) twice a week for 20 weeks. For the other two groups, the mice were treated with EGCG or AcEGCG (1 and 5 μμ in 200 μl acetone) 30 min before each TPA treatment. Tumors of at least 1 mm of diameter in an electronic digital caliper were counted and recorded twice every week and the diameters of skin tumors were measured at the same time. The results were expressed as the average number of tumors per mouse, percentage of tumorbearing mice, weight of tumors per mouse and size distribution per mouse. Western blot analysis For protein isolation from mouse skin, the dorsal skins of mice derived from different experiments were excised. After the fat from the dorsal skin was removed on ice, the skin samples were immediately placed in liquid nitrogen. The epidermal and tumor protein were homogenized on ice for 15 s using a Polytron tissue homogenizer and then lysed in 0.5 ml ice-cold lysis buffer (50 mm Tris-HCl, ph 7.4, 1 mm NaF, 150 mm NaCl, 1 mm ethyleneglycol-bis(aminoethylether)-tetraacetic 1316 acid, 1 mm phenylmethane-sulfonyl fluoride, 1% NP-40 and 10 μg/ml leupeptin) on ice for 30 min, followed by centrifugation at g for 30 min at 4 C. The samples (50 μg of protein) were mixed with 5 sample buffer containing 0.3 M Tris-HCl (ph 6.8), 25% 2-mercapto-ethanol, 12% sodium dodecyl sulfate, 25 mm ethylenediaminetetraacetic acid, 20% glycerol and 0.1% bromophenol blue. The mixtures were boiled at 100 C for 5 min and were then subjected to stacking gel, following which, they were resolved by 12% sodium dodecyl sulfate polyacrylamide minigels at a constant current of 20 ma. Subsequently, electrophoresis was carried out on sodium dodecyl sulfate polyacrylamide gels. For western blot analysis, proteins on the gel were electrotransferred onto a 45 μ immobile membrane (polyvinylidene difluoride; Millipore Corp., Bedford, MA) with transfer buffer composed of 25 mm Tris-HCl (ph 8.9), 192 mm glycine and 20% methanol. The membranes were blocked with a solution of 20 mm Tris-HCl (ph 7.4), 0.2% Tween 20, 1% bovine serum albumin and 0.1% sodium azide. The membrane was further incubated with specific antibodies, at appropriate dilution (1: 1000) using blocking solution with the primary antibodies overnight at 4 C. The membranes were subsequently probed with anti-mouse or anti-rabbit IgG antibody conjugated to horseradish peroxidase (Transduction Laboratories, Lexington, KY) and visualized using enhanced chemiluminescence (Amersham). The densities of the bands were quantified using a computer densitometer (AlphaImagerTM 2200 System). All membranes were stripped and reprobed for β-actin, glyceraldehyde 3-phosphate dehydrogenase and Lamin B (Sigma Chemical Co.) as loading control. Electrophoretic mobility shift assay Cytosolic and nuclear proteins were extracted as described previously (16). The electrophoretic mobility shift assay analysis was performed with a nonradioactive (biotin label) gel shift assay according to the manufacturer s protocol. The NF-κB (5 -AGTTGAGGGGACTTTCCCAGGC-3 ) and CREB (5 -AGAGATTGCCTGACGTCAGAGAGCTAG-3 ) consensus oligonucleotide probes were end labeled with biotin (Pierce, Rockford, IL) with terminal deoxynucleotidyl transferase. For the binding reaction, 6 μg of nuclear extract protein was incubated in a total volume of 20 μl with binding buffer containing 50 fmol of biotin end-labeled oligonucleotide. The mixture was incubated at room temperature for 20 min. The specificity was determined by adding a 100-fold excess of unlabeled double-stranded consensus oligonucleotide to the reaction mixture to act as a competition reaction. Following addition of 5 μl of sample buffer, the DNA protein complexes were resolved on a 6% non-denaturing polyacrylamide gel in a 0.5 Tris-borate-ethylenediaminetetraacetic acid buffer at 100 V for 2 h and then transferred to nylon membrane. Finally, the biotin-labeled DNA was detected by chemiluminescence using the LightShift Chemiluminescent EMSA Kit (Pierce, Rockford, IL) and exposed to X-ray film. Measurement of mitotic index Multiple formalin-fixed skin and tumor sections were stained with hematoxylin and eosin (H&E) and analyzed for mitosis using a method described previously (17). To determine the mitotic index, all various mitotic stages including prophase, metaphase, anaphase, telophase and cytokinesis were calculated with a 400-fold magnification. In this way, a total of 1000 cells (~50 cells per microscopic field) from epidermis and papillomas were counted for each lesion, and results were presented as a percentage of mitosis per total cells. Immunohistochemical analysis Three micrometer sections of skin and tumor were deparaffinized, rehydrated and treated with 0.3% hydrogen peroxide (H2O2) for 15 min to block endogenous peroxidase. Sections were pressure cooked (4 7 min) in 10 mm citrate buffer, ph 6.0 (Immuno DNA retriever with citrate, BIO SB, Santa Barbara, CA) to unmask epitopes. Sections were incubated with primary antibody to CD34 and PKD1 (1:200 dilutions in phosphate-buffered saline) for 1 h. Immunoreactivity was determined using biotin-labeled secondary antibody and streptavidin biotin peroxidase for 30 min each. 3,3 -Diaminobenzidine tetrahydrochloride (0.05%) was used as the substrate, and positive signal was detected as a brown color under a light microscope. The detailed procedures for the stained tissue analysis method were reported previously (18). For PKD1, the criterion for positive expression was membrane staining. For the immunoreactive score, the scores for the percentage of positive cells and the staining intensity were multiplied. PKD1 kinase activity assay The PKD kinase activity assay was performed as in Triantafyllou et al. (19), following immunoprecipitation of PKD using the Bioss PKD antibodies. Transient transfection The wild-type HA-PKD1 plasmid have been described previously (17) and acquired from Addgene ( A431 cells were transient transfections and harvested 24 h after transfection.

3 AcEGCG prevents skin carcinogenesis in mice Statistical analysis Relative expression values are given as the mean ± SE for the indicated fold of expression in the skin and papillomas of mice. SigmaPlot 10.0 software was used for illustration and analysis. Statistical analyses were performed using two-way analysis of variance with subsequent Bonferroni post hoc test for pairwise comparisons between two particular groups. A P value of <0.05 was considered statistically significant. Results AcEGCG prevented DMBA-initiated and TPA-promoted mouse skin tumorigenesis more effectively than EGCG We first investigated the antitumor-promoting activity of EGCG and AcEGCG on DMBA/TPA-mediated skin tumorigenesis in female ICR mice (Figure 1). Throughout the experiment, there was no noticeable difference in weight gain between the mice treated with two doses of EGCG or AcEGCG and those not treated, indicating that the topical application of EGCG or AcEGCG did not result in systemic toxicity. Topical pretreatment with AcEGCG at the higher dose resulted in a lower tumor incidence (percentage of tumor-bearing mice; Figure 1A) and lower tumor multiplicity (average number of tumors per mouse; Figure 1B). The tumor promotion data were also analyzed in terms of the papilloma size distribution and compared with the DMBA + TPA-treated group. The number of papillomas (1 3 mm in diameter) per mouse was inhibited in a dose-dependent manner in the EGCG- and AcEGCG-pretreated groups (Figure 1C). Compared with the EGCG-pretreatment groups, AcEGCG-pretreatment groups showed a significant inhibition in the number of tumors that are 3 5 mm and 5 mm in size (Figure 1C); tumor weight was also inhibited by AcEGCG pretreatment (Figure 1D). AcEGCG inhibited DMBA/TPA-promoted tumor proliferation by reducing the mitotic index Increases in the mitotic index and induction of cell cycle regulators have been well demonstrated during DMBA/TPA-induced skin tumor formation (20). To determine whether the observed hyperplasia was caused by increased mitosis, the mitotic index was calculated using H&E-stained sections of dorsal skin and papillomas. Figure 2A shows representative H&E-stained sections of dorsal skin and papillomas after DMBA treatment followed by acetone, TPA, 1 μμ AcEGCG or 5 μμ AcEGCG treatment. Histological examination of the tissue sections revealed that AcEGCG significantly reduced hyperplasia in the papillomas and their mitotic index (Figure 2B; P < 0.05). We next analyzed the expression of cell cycle regulators. Although many studies have shown that p53 and p21 are downregulated in cancer cells (18), it has also been reported that p53 expression is increased in keratoacanthomas (19) and DMBA/TPA-treated tissues (20). In addition, deregulation and elevated expression of Myc have also been observed to lead to significant increases in cell proliferation and tumorigenesis (21). In this study, topical pretreatment of AcEGCG at both doses, 30 min prior to TPA application, markedly inhibited the expression of p53, p21 and c-myc (Figure 2C). Indeed, progression through mitosis requires the coordinated regulation of cyclin B1/cyclindependent kinase (Cdk) 1 activity. Previous studies have suggested that cyclin B1/CDK1 complex assembly and dephosphorylation of Cdk1 during G 2 /M phase is tightly coupled and regulated by Cdc25 phosphatases (22). Thus, downregulation of Cdc25A leads to an induction of G 2 /M phase arrest. Cdc25A has been shown to be degraded by the activation of the ERK pathway and phosphorylation of Cdc25A, resulting in cell cycle arrest (23). As illustrated in Fig. 1. Inhibitory effects of EGCG and AcEGCG on DMBA-initiated and TPA-promoted mouse skin tumorigenesis. Groups of 12 female ICR mice, 6 weeks of age, were first treated with 200 nm DMBA. After 1 week of DMBA initiation, mice were topically treated twice weekly with EGCG, AcEGCG or acetone 30 min before each topical application of TPA (5 nm) for 20 weeks. (A) Tumor incidence (percentage of mice with papillomas). (B) Tumor multiplicity (average number of papillomas per mouse ± SD). (C) Average numbers of papillomas per mouse in different tumor diameter groups. (D) Weight of papillomas per mouse. Tumors of at least 1 mm diameter were counted and recorded weekly. Each bar represents the mean ± SD of the average of the 12 mice scored. Statistical significance was done by analysis of variance, *P < 0.05; **P < 0.01; ***P < compared with the DMBA + TPA-treated mice or DMBA + EGCG + TPA versus DMBA + AcEGCG + TPA; # P < compared with the DMBA + Ac group. Results were statistically analyzed by analysis of variance. a P < 0.05; b P < 0.01; c P < EGCG (1 μm) versus EGCG (5 μm), and AcEGCG (1 μm) versus AcEGCG (5 μm). 1317

4 Y-S.Chiou et al. Fig. 2. The effects of AcEGCG on the DMBA/TPA-induced mitotic index and cell cycle regulators of the G 2 /M transition in mouse skin and papillomas. (A) Histochemical analysis of epidermal and tumor sections stained with H&E (200 magnification). (B) Quantification of the mitotic index. The mitotic index was evaluated as described in the Materials and methods. Papillomas of 1 3 mm size were selected and analyzed in each experiment. Each bar represents the mean ± SE of 3 6 mice scored. Statistical significance, *P < 0.05 compared with the DMBA + TPA-treated group. Equal amounts of cell lysates (50 μg of protein) were subjected to western blot analysis in C and D to determine the levels of cell cycle regulators. C: DMBA treatment. Quantification of protein level was normalized to β-actin using densitometry. The results are representative of three independent experiments. Figure 2D, topical pretreatment with AcEGCG dramatically inhibited the levels of cyclin B and Cdc25 proteins and enhanced the levels of p-erk1/2 and Tyr15 p-cdk1. These results suggest that pretreatment with AcEGCG could lead to the activation of ERK, the degradation of Cdc25A and the inhibition of cyclin B1/CDK1 complex assembly; these effects cause G 2 /M phase arrest and block mitotic progression. AcEGCG suppressed DMBA/TPA-induced PKD1 activation and CD34 expression PKD1 can be activated by TPA, which initiates keratinocyte hyperproliferation, abnormal differentiation and inflammation through the increased expression of PKD1; these effects occur as the result of the autophosphorylation of ser 916 and transphosphorylation of ser744/748 (24,25). Recent evidence also suggests an important function for CD34 in DMBA/TPA-induced skin tumorigenesis (26). This research indicated that CD34 is required for TPA-induced skin stem cell activation and tumor formation in mice (2). As illustrated in Supplementary Figure 1A and B, available at Carcinogenesis Online, topical application of TPA (A) or DMBA (B) over 12 h greatly increased the protein levels of PKD1 and CD34. To understand the correlation between PKD1 activation and CD34 expression in DMBA/TPA-induced skin tumor initiation and progression, the PDK1 and CD34 levels were examined using immunohistochemical analysis. The levels of PKD1 and the skin CSC marker, CD34, were significantly higher in DMBA/TPA-induced mice compared with the untreated group (Figure 3). AcEGCG pretreatments significantly lowered DMBA and/or TPA-induced levels of PKD1 and CD34 (Figure 3 and Supplementary Figure 1C, available at Carcinogenesis Online). We next examined whether AcEGCG inhibited activation of PKD1 using a co-immunoprecipitation strategy, in which we immunoprecipitated PKD1 and analyzed the resulting kinase activity. Western blots 1318 and kinase activity assays demonstrated that AcEGCG significantly suppressed DMBA/TPA-induced PKD1 levels, serine phosphorylation (at ser916 and ser744/748) and active PKD1 levels (Figure 4A and B). To determine whether AcEGCG directly inhibited PKD1, we measured purified PKD1 (2 ng) activity in the presence of 5 and 25 μm AcEGCG. Surprisingly, we found that the kinase activity of purified PKD1 was inhibited by AcEGCG in a dose-dependent manner to a level of 70% (Figure 4C). These data support the direct inhibition of PKD1 by AcEGCG. Our results strongly suggest that the overexpression and activation of PKD1 in CD34 + skin stem cells and skin tumors are potential targets for the treatment of skin carcinogenesis. AcEGCG blocked DMBA/TPA-induced activation of the p38, JNK1/2 and PI3K/Akt signaling pathways and downregulated target protein expression Although we demonstrated that PKD1 is a key regulator of the inhibition of tumor formation by AcEGCG, the downstream signaling targets of the MAPKs and PI3K/Akt pathways in skin tumorigenesis remain to be identified. Studies have shown that inflammatory and proliferative protein expression is controlled by the MAPKs and PI3K/Akt pathways. We and others have previously also shown that the transcription of inos, COX-2, VEGF and ODC is regulated by C/EBPs, NF-κB and CREB, which are required for the DMBA/TPAinduced tumor inflammation and proliferation (27 39). To further explore the potential mechanisms by which AcEGCG inhibited DMBA/TPA-induced epidermal hyperproliferation and skin tumor promotion, experiments were conducted to evaluate the changes in various members of the epidermal and papilloma signaling pathways (p38, JNK1/2 and PI3K/Akt) and well-known biomarkers of inflammation and tumor promotion (inos, COX-2, ODC and VEGF). Pretreatment with AcEGCG at a dose of 1 or 5 μμ resulted in a decrease in the levels of phosphorylated JNK1/2, p38 and PI3K/

5 AcEGCG prevents skin carcinogenesis in mice Fig. 3. Inhibitory effect of AcEGCG on DMBA/TPA-induced activation of PKD1 in CD34 + skin stem cells and CSCs. (A) Staining and (B) quantification patterns of PKD1 and CD34 protein levels in mouse skin and papillomas (100 magnification). Papillomas of 1 3 mm size were selected and analyzed in each experiment. Positive expressing cells are stained brown. Each bar represents the mean ± SE of 3 6 mice scored. Statistical significance, *P < 0.05; **P < 0.01 compared with the DMBA + TPA-treated group. Fig. 4. Inhibitory effect of AcEGCG on TPA and DMBA/TPA-induced activation of PKD1 in mouse skin and papillomas. (A) PKD1 immunoprecipitation from control, DMBA/TPA or DMBA + AcEGCG + TPA-treated skin and papilloma lysates. The concentration of active PKD1 was measured by enzyme-linked immunosorbent assay-based assay from Enzo Life Sciences. Each bar represents the mean ± SE of three mice scored. Statistical significance, *P < 0.05 compared with the DMBA + TPA-treated group. (B) Equal amounts of cell lysate (50 μg of protein) were subjected to western blot analysis to determine the activation of PKD1. Papillomas of 1 3 mm size were selected and analyzed in each experiment. Quantification of protein level was normalized to β-actin using densitometry. A431 cells were transfected with HA-PKD1 and used as a positive control to verify PKD1 band. Endogenous (PKD, down band) and expressed PKD (HA-PKD1, up band) were detected on anti-pkd 1 immunoblot. The results are representative of three independent experiments. C: DMBA treatment. (C) Inhibitory activity of AcEGCG was determined in the presence of 2 ng purified PKD1. Each bar represents the average of triplicate determinations. Statistical significance, **P < 0.01 compared with the active PKD1-treated group. 1319

6 Y-S.Chiou et al. Fig. 5. Inhibitory effect of AcEGCG on DMBA/TPA-stimulated nuclear translocation of NF-κB, C/EBPβ and C/EBPδ and the activation of the MAPKs and PI3K/Akt signaling pathways. Western blot analysis of PI3K/Akt and MAPKs signaling molecules (A and B) and downstream transcription factors (C). Total tissue lysates or nuclear and cytosolic extracts were prepared from mouse skin and papillomas. C: DMBA treatment. Papillomas of 1 3 mm size were selected and analyzed in each experiment. The western bolt is representative of at least three independent experiments. Akt compared with the levels in DMBA/TPA-mediated tumors (Figure 5A and B). The protein levels of NF-κB, C/EBPβ and C/ EBPδ in nuclear fractions were markedly inhibited by AcEGCG pretreatment (Figure 5C). Previous studies indicate that PKD1 is a mediator of NF-κB and CREB induction (30 32). Activation of NF-κB can act via the phosphorylation and degradation of IκBα, resulting in the nuclear translocation and DNA binding of NF-κB. It has been reported that histone protein substrate acetylation by histone acetyltransferases is crucial for the generation of a chromatinrelaxation state and gene transcription (33). We also observed that the DMBA/TPA stimulation of NF-κB and CREB-DNA-binding activity was attenuated by pretreatment with AcEGCG in a dose-dependent manner (Figure 6A and B). Topical pretreatment with AcEGCG not only decreased the expression of the p-p65, IκBα and acetylhistone 3 lysine 9 proteins but also significantly increased the level of IκBα in mouse papillomas (Figure 6C). In addition, preapplication of AcEGCG markedly suppressed the expression of inos, COX-2, ODC and VEGF by DMBA/TPA treatment (Figure 6D). Overall, we speculate that AcEGCG exerts antiproliferative and/or antiinflammatory effects in CD34 + skin stem cells and skin tumors and that the suppression of PKD1 activity and its downstream signaling pathways may be involved in the prevention of skin carcinogenesis. Discussion In this study, we investigated the differences in chemopreventive potency of AcEGCG and EGCG for DMBA/TPA-induced murine skin tumorigenesis (Figure 1). The mitotic index, a measure of the percentage of cells undergoing mitosis, is an established indicator of tumor proliferation. Earlier findings have shown mitosis to be an important target for anticancer therapies. The cyclin B1/CDK1 complex controls mitotic entrance from G 2 to M phase. In fact, inhibiting aberrant activity of cyclin B1/CDK1 in tumor cells leads to mitotic arrest and consequently, although not always, to cell death (34). Previous studies have 1320 reported that DMBA-initiated skin tissue has significantly increased the levels of mitochondrial p53 and the survival response mediated by cyclin B1/CDK1 phosphorylation at ser-315 of p53 (35,36). However, our present data cannot prove that ser-315 of p53 is phosphorylated by mitochondrial cyclin B1/CDK1 in DMBA/TPA-induced mouse papillomas, thus avoiding the pathway toward apoptosis. Analysis of H&E-stained dorsal skin and papillomas showed that topical pretreatment with AcEGCG could significantly decrease the proliferation of epidermal cells and induce G 2 /M phase arrest by inhibition of cyclin B1/CDK1 activity (Figure 2). Previous studies have reported that aberrant activation and upregulation of PKD1 might be involved in various cellular functions that are potentially significant in skin tumor development, such as proliferation, survival, apoptosis and differentiation (4,37,38). In vitro analysis of keratinocytes exposed to ultraviolet B radiation revealed the inhibition of apoptosis due to the overexpression of wild-type PKD1, suggesting a putative tumorigenic role of PKD1 in the skin (39). Since their discovery, the non-selective PKD1 inhibitor (resveratrol) and selective PKD1 inhibitor, Gö6976, have been proposed to act as antiproliferative and prodifferentiative signals in TPA-treated keratinocytes in vitro and epidermis in vivo (40). Furthermore, PKD1 can serve as a marker of sensitivity to skin carcinogenesis. In addition, PKD1 and CD34 have also been defined and isolated based on their locations within cutaneous stem cells, where they potentially mediate CSC activation and promote skin carcinogenesis (26). The results of this study further confirmed and provided new evidence that DMBA/TPA-induced skin tumorigenesis occurs via the induction of CD34 expression and the activation of PKD1-regulated downstream signaling, including the p38, JNK1/2 and PI3K/Akt pathways (Figures 3 5). Activation of multiple kinases leads to the phosphorylation and upregulation of downstream transcription factor activity, including C/EBPs, NF-κB and CREB, which transcribe proinflammatory and proproliferative genes, including inos, COX- 2, ODC and VEGF (Figures 5C and 6). In addition to transcription factors, acetylation of acetyl-histone 3 lysine 9 has been shown to

7 AcEGCG prevents skin carcinogenesis in mice Fig. 6. Inhibitory effect of AcEGCG on DMBA/TPA-regulated DNA-binding activity of NF-κB and C/EBP and transcription of downstream target proteins. For analysis by the electrophoretic mobility shift assay, nuclear extracts were prepared and incubated with biotin-labeled (non-radioactive) oligonucleotides containing the (A) NF-κB and (B) CREB sequences. (C and D) Equal amounts of cell lysates (50 μg of protein) were subjected to western blot analysis to determine the levels of p-p65, p-iκbα, IκBα, inos, COX-2, ODC and VEGF. C: DMBA treatment. Quantification of protein level was normalized to β-actin using densitometry. The results are representative of three independent experiments. Papillomas of 1 3 mm size were selected and analyzed in each experiment. be involved in promoting the transcriptional activity of target genes in DMBA/TPA-treated mouse papillomas (Figure 6C). In an in vitro kinase assay, we first demonstrated that treatment with 5 and 25 μm AcEGCG could directly inhibit PKD1 activity (Figure 4D). Additionally, our study clearly showed that topical pretreatment of AcEGCG not only abated CD34 expression and the activation of multiple kinases but also suppressed C/EBPs, NF-κB and CREBmediated target gene expression in DMBA/TPA-treated mouse papillomas (Supplementary Figure 2, available at Carcinogenesis Online). In this study, we found that there is little dose-dependent response of AcEGCG in inhibiting PKD1 activity at an early stage of signaling pathways. We suggest that AcEGCG could be quite successful in improving the biological activity and bioavailability of EGCG. Therefore, AcEGCG more effectively exerts cancer chemopreventive ability in lower concentration. In this study, we also analyzed CD34 and PKD1 expression levels in human keratinocytes (HaCaT) and human epithelial carcinoma cells (A431) and found that A431 cells had an ~4-fold induction of CD34 and PKD1 expression compared with HaCaT cells. In addition, CD34 and PKD1 upregulation correlated with a fast proliferative potential (Supplementary Figure 3, available at Carcinogenesis Online). This is also the first study to find that AcEGCG could suppress cell proliferation by decreasing PKD1 and CD34 levels in A431 cells (Supplementary Figure 3, available at Carcinogenesis Online). Thus, we identified CD34 and PKD1 as proproliferative genes in epithelial carcinoma cells and as prognostic factors for the prediction of clinical outcome. Although numerous studies support the importance of PKD1 in processes related to proliferation in many tumor cell types, including keratinocytes, there are currently no specific, effective and safe inhibitors of PKD1 available. Targeting CD34 in conjunction with PKD1 inhibitors could become a viable option for the development of new and more effective multitarget strategies for preventing skin carcinogenesis. Taken together, our findings have substantial implications because AcEGCG may serve as a novel chemopreventive and therapeutic agent that could inhibit PKD1 activity and the inflammation associated with tumorigenesis. Supplementary material Supplementary Figures 1 3 can be found at Funding National Science Council (NSC B MY3, B MY4). Conflict of Interest Statement: None declared. References 1. Affara,N.I. et al. (2006) Activation of Akt and mtor in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis. Anticancer Res., 26, Malanchi,I. et al. (2008) Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature, 452, Ivanova,P. et al. (2008) Knockdown of PKD1 in normal human epidermal keratinocytes increases mrna expression of keratin 10 and involucrin: early markers of keratinocyte differentiation. Arch. Dermatol. Res., 300, Ristich,V.L. et al. (2006) Protein kinase D distribution in normal human epidermis, basal cell carcinoma and psoriasis. Br. J. Dermatol., 154, Bollag,W.B. et al. (2011) Ultraviolet activation of PKD: implications for skin cancer. Future Oncol., 7, Sundram,V. et al. (2011) Emerging roles of protein kinase D1 in cancer. Mol. Cancer Res., 9, Abel,E.L. et al. (2009) Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat. Protoc., 4, Gupta,S. et al. (2002) Chemoprevention of skin cancer: current status and future prospects. Cancer Metastasis Rev., 21, Singh,B.N. et al. (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol., 82, Lambert,J.D. et al. (2006) Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab. Dispos., 34,

8 Y-S.Chiou et al. 11. Landis-Piwowar,K.R. et al. (2007) A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res., 67, Lee,S.C. et al. (2008) Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Nutr. Cancer, 60, Meeran,S.M. et al. (2011) A novel prodrug of epigallocatechin-3-gallate: differential epigenetic htert repression in human breast cancer cells. Cancer Prev. Res. (Phila)., 4, Chiou,Y.S. et al. (2012) Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J. Agric. Food Chem., 60, Chiou,Y.S. et al. (2011) Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. J. Agric. Food Chem., 59, Triantafyllou,A. et al. (2011) Anti-inflammatory activity of Chios mastic gum is associated with inhibition of TNF-alpha induced oxidative stress. Nutr. J., 10, Storz,P. et al. (2003) Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J., 22, Roger,L. et al. (2006) Control of cell migration: a tumour suppressor function for p53? Biol. Cell, 98, Yao,D. et al. (2008) Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21 WAF-induced differentiation triggered by GSK3beta inactivation and reduced AKT activity. J. Cell. Sci., 121(Pt 10), Zhao,Y. et al. (2002) Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. Oncogene, 21, Hurlin,P.J. et al. (2004) Functions of myc:max in the control of cell proliferation and tumorigenesis. Int. Rev. Cytol., 238, Timofeev,O. et al. (2010) Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition. J. Biol. Chem., 285, Isoda,M. et al. (2009) The extracellular signal-regulated kinase-mitogenactivated protein kinase pathway phosphorylates and targets Cdc25A for SCF beta-trcp-dependent degradation for cell cycle arrest. Mol. Biol. Cell, 20, Ernest,D.M. et al. (2005) Regulation of protein kinase D during differentiation and proliferation of primary mouse keratinocytes. J. Invest. Dermatol., 125, Fu,Y. et al. (2011) Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology. EMBO Rep., 12, Trempus,C.S. et al. (2007) CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res., 67, Lai,C.S. et al. (2008) Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3,4 -didemethylnobiletin, derived from nobiletin. Carcinogenesis, 29, Chung,W.Y. et al. (2007) Xanthorrhizol inhibits 12-O-tetradecanoylphorbol- 13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogenactivated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis, 28, Rozenberg,J. et al. (2009) Inhibition of CREB function in mouse epidermis reduces papilloma formation. Mol. Cancer Res., 7, Guo,J. et al. (2011) Protein kinase D isoforms are activated in an agonistspecific manner in cardiomyocytes. J. Biol. Chem., 286, Rozengurt,E. (2011) Protein kinase D signaling: multiple biological functions in health and disease. Physiology (Bethesda)., 26, Yuan,J. et al. (2008) Protein kinase D1 mediates NF-kappaB activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol., 295, G1190 G Lopez,J. et al. (2009) The context and potential of epigenetics in oncology. Br. J. Cancer, 100, Yuan,J. et al. (2004) Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene, 23, Zhao,Y. et al. (2006) Ras mutation promotes p53 activation and apoptosis of skin keratinocytes. Carcinogenesis, 27, Nantajit,D. et al. (2010) Cyclin B1/Cdk1 phosphorylation of mitochondrial p53 induces anti-apoptotic response. PLoS ONE, 5, e Rennecke,J. et al. (1999) Protein-kinase-Cmu expression correlates with enhanced keratinocyte proliferation in normal and neoplastic mouse epidermis and in cell culture. Int. J. Cancer, 80, Jadali,A. et al. (2010) Protein kinase D is implicated in the reversible commitment to differentiation in primary cultures of mouse keratinocytes. J. Biol. Chem., 285, Arun,S.N. et al. (2011) Ultraviolet B irradiation and activation of protein kinase D in primary mouse epidermal keratinocytes. Oncogene, 30, Arun,S.N. et al. (2010) The potential use of protein kinase D inhibitors for prevention/treatment of epidermal tumors. J. Dermatol. Sci., 60, Received September 14, 2012; revised January 14, 2013; accepted January 29,

Part-4. Cell cycle regulatory protein 5 (Cdk5) A novel target of ERK in Carb induced cell death

Part-4. Cell cycle regulatory protein 5 (Cdk5) A novel target of ERK in Carb induced cell death Part-4 Cell cycle regulatory protein 5 (Cdk5) A novel target of ERK in Carb induced cell death 95 1. Introduction The process of replicating DNA and dividing cells can be described as a series of coordinated

More information

Electrical Stimulation Control Nerve Regeneration via the p38 Mitogen-activated Protein Kinase and CREB

Electrical Stimulation Control Nerve Regeneration via the p38 Mitogen-activated Protein Kinase and CREB Electrical Stimulation Control Nerve Regeneration via the p38 Mitogen-activated Protein Kinase and CREB Kenji Kawamura, Yoshio Kano. Kibi International University, Takahashi-city, Japan. Disclosures: K.

More information

Protocol for Gene Transfection & Western Blotting

Protocol for Gene Transfection & Western Blotting The schedule and the manual of basic techniques for cell culture Advanced Protocol for Gene Transfection & Western Blotting Schedule Day 1 26/07/2008 Transfection Day 3 28/07/2008 Cell lysis Immunoprecipitation

More information

Summary & conclusion

Summary & conclusion Summary & conclusion Cancer is the prime cause of death in developed countries and the second major cause of death in developing world. The early diagnosis is very crucial for the effective treatment of

More information

Supplementary data Supplementary Figure 1 Supplementary Figure 2

Supplementary data Supplementary Figure 1 Supplementary Figure 2 Supplementary data Supplementary Figure 1 SPHK1 sirna increases RANKL-induced osteoclastogenesis in RAW264.7 cell culture. (A) RAW264.7 cells were transfected with oligocassettes containing SPHK1 sirna

More information

The Schedule and the Manual of Basic Techniques for Cell Culture

The Schedule and the Manual of Basic Techniques for Cell Culture The Schedule and the Manual of Basic Techniques for Cell Culture 1 Materials Calcium Phosphate Transfection Kit: Invitrogen Cat.No.K2780-01 Falcon tube (Cat No.35-2054:12 x 75 mm, 5 ml tube) Cell: 293

More information

BCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney

BCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney BCHM3972 Human Molecular Cell Biology (Advanced) 2013 Course University of Sydney Page 2: Immune Mechanisms & Molecular Biology of Host Defence (Prof Campbell) Page 45: Infection and Implications for Cell

More information

Supplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION

Supplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION Supplementary Information POLO-LIKE KINASE 1 FACILITATES LOSS OF PTEN-INDUCED PROSTATE CANCER FORMATION X. Shawn Liu 1, 3, Bing Song 2, 3, Bennett D. Elzey 3, 4, Timothy L. Ratliff 3, 4, Stephen F. Konieczny

More information

Phospho-AKT Sampler Kit

Phospho-AKT Sampler Kit Phospho-AKT Sampler Kit E 0 5 1 0 0 3 Kits Includes Cat. Quantity Application Reactivity Source Akt (Ab-473) Antibody E021054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit Akt (Phospho-Ser473) Antibody

More information

Supplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells

Supplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells Supplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells (b). TRIM33 was immunoprecipitated, and the amount of

More information

Chapter-VI. Chemopreventive effects of silibinin against DMBA-initiated and TPA-promoted two-stage skin tumorigenesis in Swiss albino mice

Chapter-VI. Chemopreventive effects of silibinin against DMBA-initiated and TPA-promoted two-stage skin tumorigenesis in Swiss albino mice Chemopreventive effects of silibinin against DMBA-initiated and TPA-promoted two-stage skin tumorigenesis in Swiss albino mice Introduction Inflammation is one of the most important etiological factors

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION FOR Liver X Receptor α mediates hepatic triglyceride accumulation through upregulation of G0/G1 Switch Gene 2 (G0S2) expression I: SUPPLEMENTARY METHODS II: SUPPLEMENTARY FIGURES

More information

Synthesis and Biological Evaluation of Protein Kinase D Inhibitors

Synthesis and Biological Evaluation of Protein Kinase D Inhibitors Synthesis and Biological Evaluation of Protein Kinase D Inhibitors Celeste Alverez Topic Seminar October 26, 2013 Celeste Alverez @ Wipf Group 10/26/2013 1 Protein Kinase D (PKD) A novel family of serine/threonine

More information

Effect of Taurine on Acinar Cell Apoptosis and Pancreatic Fibrosis in Dibutyltin Dichloride-induced Chronic Pancreatitis

Effect of Taurine on Acinar Cell Apoptosis and Pancreatic Fibrosis in Dibutyltin Dichloride-induced Chronic Pancreatitis 212 66 4 329334 Effect of Taurine on Acinar Cell Apoptosis and Pancreatic Fibrosis in Dibutyltin Dichloride-induced Chronic Pancreatitis a,c a* b b a a b a a b c 33 66 4 ʼ 6 6 6 28 6 5 5 5 28 45 ʼ ʼ ʼ

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Figures Supplementary Figure S1. Binding of full-length OGT and deletion mutants to PIP strips (Echelon Biosciences). Supplementary Figure S2. Binding of the OGT (919-1036) fragments with

More information

RAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes.

RAS Genes. The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. ۱ RAS Genes The ras superfamily of genes encodes small GTP binding proteins that are responsible for the regulation of many cellular processes. Oncogenic ras genes in human cells include H ras, N ras,

More information

Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell

Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines Yan-Shen Shan 1, Hui-Ping Hsu 1, Ming-Derg Lai 2,3, Meng-Chi Yen 2,4, Wei-Ching Chen

More information

hexahistidine tagged GRP78 devoid of the KDEL motif (GRP78-His) on SDS-PAGE. This

hexahistidine tagged GRP78 devoid of the KDEL motif (GRP78-His) on SDS-PAGE. This SUPPLEMENTAL FIGURE LEGEND Fig. S1. Generation and characterization of. (A) Coomassie staining of soluble hexahistidine tagged GRP78 devoid of the KDEL motif (GRP78-His) on SDS-PAGE. This protein was expressed

More information

Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein

Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein Lei Wang 1, Tian-Peng Zhang 1, Yuan Zhang 2, Hai-Lian

More information

RayBio KinaseSTAR TM Akt Activity Assay Kit

RayBio KinaseSTAR TM Akt Activity Assay Kit Activity Assay Kit User Manual Version 1.0 March 13, 2015 RayBio KinaseSTAR TM Akt Activity Kit Protocol (Cat#: 68AT-Akt-S40) RayBiotech, Inc. We Provide You With Excellent Support And Service Tel:(Toll

More information

p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO

p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO Supplementary Information p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO Yuri Shibata, Masaaki Oyama, Hiroko Kozuka-Hata, Xiao Han, Yuetsu Tanaka,

More information

Supplementary Information

Supplementary Information Supplementary Information Supplementary Figure 1. CD4 + T cell activation and lack of apoptosis after crosslinking with anti-cd3 + anti-cd28 + anti-cd160. (a) Flow cytometry of anti-cd160 (5D.10A11) binding

More information

Growth and Differentiation Phosphorylation Sampler Kit

Growth and Differentiation Phosphorylation Sampler Kit Growth and Differentiation Phosphorylation Sampler Kit E 0 5 1 0 1 4 Kits Includes Cat. Quantity Application Reactivity Source Akt (Phospho-Ser473) E011054-1 50μg/50μl IHC, WB Human, Mouse, Rat Rabbit

More information

C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is

C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is ' ^Summary C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein pigment isolated from Spirulina platensis. This water- soluble protein pigment is of greater importance because of its various

More information

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14- 1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish

More information

Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, Doctoral Degree Program in Marine Biotechnology, Academia Sinica, Taipei,

Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, Doctoral Degree Program in Marine Biotechnology, Academia Sinica, Taipei, Cyclooxygenase 2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents Chun-Kuang Lin 1,2, Chin-Kai Tseng 3,4, Yu-Hsuan Wu 3,4, Chih-Chuang Liaw 1,5, Chun-

More information

Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) Catalog Number KA1538 48 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use...

More information

1. Materials and Methods 1.1 Animals experiments process The experiments were approved by the Institution Animal Ethics Committee of Jilin University

1. Materials and Methods 1.1 Animals experiments process The experiments were approved by the Institution Animal Ethics Committee of Jilin University 1. Materials and Methods 1.1 Animals experiments process The experiments were approved by the Institution Animal Ethics Committee of Jilin University (Reference NO. 2015-003). 96 Kunming (KM) mice (8 weeks;

More information

Rabbit Polyclonal antibody to NFkB p65 (v-rel reticuloendotheliosis viral oncogene homolog A (avian))

Rabbit Polyclonal antibody to NFkB p65 (v-rel reticuloendotheliosis viral oncogene homolog A (avian)) Datasheet GeneTex, Inc : Toll Free 1-877-GeneTex (1-877-436-3839) Fax:1-949-309-2888 info@genetex.com GeneTex International Corporation : Tel:886-3-6208988 Fax:886-3-6208989 infoasia@genetex.com Date :

More information

TFEB-mediated increase in peripheral lysosomes regulates. Store Operated Calcium Entry

TFEB-mediated increase in peripheral lysosomes regulates. Store Operated Calcium Entry TFEB-mediated increase in peripheral lysosomes regulates Store Operated Calcium Entry Luigi Sbano, Massimo Bonora, Saverio Marchi, Federica Baldassari, Diego L. Medina, Andrea Ballabio, Carlotta Giorgi

More information

Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis

Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis Cell cycle, signaling to cell cycle, and molecular basis of oncogenesis MUDr. Jiří Vachtenheim, CSc. CELL CYCLE - SUMMARY Basic terminology: Cyclins conserved proteins with homologous regions; their cellular

More information

Supplementary Figure 1

Supplementary Figure 1 Supplementary Figure 1 Supplementary Figure 1. Neither the activation nor suppression of the MAPK pathway affects the ASK1/Vif interaction. (a, b) HEK293 cells were cotransfected with plasmids encoding

More information

Regulators of Cell Cycle Progression

Regulators of Cell Cycle Progression Regulators of Cell Cycle Progression Studies of Cdk s and cyclins in genetically modified mice reveal a high level of plasticity, allowing different cyclins and Cdk s to compensate for the loss of one

More information

SUPPLEMENTAL MATERIALS AND METHODS. Puromycin-synchronized metabolic labelling - Transfected HepG2 cells were depleted of

SUPPLEMENTAL MATERIALS AND METHODS. Puromycin-synchronized metabolic labelling - Transfected HepG2 cells were depleted of SUPPLEMENTAL MATERIALS AND METHODS Puromycin-synchronized metabolic labelling - Transfected HepG2 cells were depleted of cysteine and methionine and then treated with 10 μm puromycin in depletion medium

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Table 1. Cell sphingolipids and S1P bound to endogenous TRAF2. Sphingolipid Cell pmol/mg TRAF2 immunoprecipitate pmol/mg Sphingomyelin 4200 ± 250 Not detected Monohexosylceramide 311 ± 18

More information

Li et al. Journal of Experimental & Clinical Cancer Research (2018) 37:108

Li et al. Journal of Experimental & Clinical Cancer Research (2018) 37:108 Li et al. Journal of Experimental & Clinical Cancer Research (2018) 37:108 https://doi.org/10.1186/s13046-018-0774-7 CORRECTION Correction to: Novel smac mimetic APG- 1387 elicits ovarian cancer cell killing

More information

Supplementary Figure 1. Normal T lymphocyte populations in Dapk -/- mice. (a) Normal thymic development in Dapk -/- mice. Thymocytes from WT and Dapk

Supplementary Figure 1. Normal T lymphocyte populations in Dapk -/- mice. (a) Normal thymic development in Dapk -/- mice. Thymocytes from WT and Dapk Supplementary Figure 1. Normal T lymphocyte populations in Dapk -/- mice. (a) Normal thymic development in Dapk -/- mice. Thymocytes from WT and Dapk -/- mice were stained for expression of CD4 and CD8.

More information

Supplementary Material for

Supplementary Material for Supplementary Material for Parathyroid Hormone Signaling through Low-density-lipoprotein-related Protein 6 Mei Wan, Chaozhe Yang, Jun Li, Xiangwei Wu, Hongling Yuan, Hairong Ma, Xi He, Shuyi Nie, Chenbei

More information

Chemical Chaperones Mitigate Experimental Asthma By Attenuating Endoplasmic

Chemical Chaperones Mitigate Experimental Asthma By Attenuating Endoplasmic Chemical Chaperones Mitigate Experimental Asthma By Attenuating Endoplasmic Reticulum Stress Lokesh Makhija, BE, Veda Krishnan, MSc, Rakhshinda Rehman, MTech, Samarpana Chakraborty, MSc, Shuvadeep Maity,

More information

A Hepatocyte Growth Factor Receptor (Met) Insulin Receptor hybrid governs hepatic glucose metabolism SUPPLEMENTARY FIGURES, LEGENDS AND METHODS

A Hepatocyte Growth Factor Receptor (Met) Insulin Receptor hybrid governs hepatic glucose metabolism SUPPLEMENTARY FIGURES, LEGENDS AND METHODS A Hepatocyte Growth Factor Receptor (Met) Insulin Receptor hybrid governs hepatic glucose metabolism Arlee Fafalios, Jihong Ma, Xinping Tan, John Stoops, Jianhua Luo, Marie C. DeFrances and Reza Zarnegar

More information

SUPPLEMENTARY INFORMATION. Supplementary Figures S1-S9. Supplementary Methods

SUPPLEMENTARY INFORMATION. Supplementary Figures S1-S9. Supplementary Methods SUPPLEMENTARY INFORMATION SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane Jian Huang 1,2#, Jie Yan 1,2#, Jian Zhang 3#, Shiguo Zhu 1, Yanli Wang

More information

Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α

Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α Negative Regulation of c-myc Oncogenic Activity Through the Tumor Suppressor PP2A-B56α Mahnaz Janghorban, PhD Dr. Rosalie Sears lab 2/8/2015 Zanjan University Content 1. Background (keywords: c-myc, PP2A,

More information

Boucher et al NCOMMS B

Boucher et al NCOMMS B 1 Supplementary Figure 1 (linked to Figure 1). mvegfr1 constitutively internalizes in endothelial cells. (a) Immunoblot of mflt1 from undifferentiated mouse embryonic stem (ES) cells with indicated genotypes;

More information

STUDIES ON MUSTARD-STIMULATED PROTEASES AND INHIBITORS IN HUMAN EPIDERMAL KERATINOCYTES (HEK): DEVELOPMENT OF ANTIVESICANT DRUGS

STUDIES ON MUSTARD-STIMULATED PROTEASES AND INHIBITORS IN HUMAN EPIDERMAL KERATINOCYTES (HEK): DEVELOPMENT OF ANTIVESICANT DRUGS STUDIES ON MUSTARD-STIMULATED PROTEASES AND INHIBITORS IN HUMAN EPIDERMAL KERATINOCYTES (HEK): DEVELOPMENT OF ANTIVESICANT DRUGS Xiannu Jin 1, Radharaman Ray 2, Guang Xu 1 and Prabhati Ray 1 1 Department

More information

Supplemental Information

Supplemental Information Supplemental Information Tobacco-specific Carcinogen Induces DNA Methyltransferases 1 Accumulation through AKT/GSK3β/βTrCP/hnRNP-U in Mice and Lung Cancer patients Ruo-Kai Lin, 1 Yi-Shuan Hsieh, 2 Pinpin

More information

EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric) Base Catalog # PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Total Histone H3 Acetylation Detection Fast Kit (Colorimetric)

More information

NFκB What is it and What s the deal with radicals?

NFκB What is it and What s the deal with radicals? The Virtual Free Radical School NFκB What is it and What s the deal with radicals? Emily Ho, Ph.D Linus Pauling Institute Scientist Department of Nutrition and Food Management Oregon State University 117

More information

Introduction: 年 Fas signal-mediated apoptosis. PI3K/Akt

Introduction: 年 Fas signal-mediated apoptosis. PI3K/Akt Fas-ligand (CD95-L; Fas-L) Fas (CD95) Fas (apoptosis) 年 了 不 度 Fas Fas-L 力 不 Fas/Fas-L T IL-10Fas/Fas-L 不 年 Fas signal-mediated apoptosis 度降 不 不 力 U-118, HeLa, A549, Huh-7 MCF-7, HepG2. PI3K/Akt FasPI3K/Akt

More information

Serum Amyloid A3 Gene Expression in Adipocytes is an Indicator. of the Interaction with Macrophages

Serum Amyloid A3 Gene Expression in Adipocytes is an Indicator. of the Interaction with Macrophages Serum Amyloid A3 Gene Expression in Adipocytes is an Indicator of the Interaction with Macrophages Yohei Sanada, Takafumi Yamamoto, Rika Satake, Akiko Yamashita, Sumire Kanai, Norihisa Kato, Fons AJ van

More information

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia

More information

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Margaret S Ebert, Joel R Neilson & Phillip A Sharp Supplementary figures and text: Supplementary Figure 1. Effect of sponges on

More information

Supporting Information

Supporting Information Supporting Information Pang et al. 10.1073/pnas.1322009111 SI Materials and Methods ELISAs. These assays were performed as previously described (1). ELISA plates (MaxiSorp Nunc; Thermo Fisher Scientific)

More information

APPENDIX Heparin 2 mg heparin was dissolved in 0.9 % NaCl (10 ml). 200 µl of heparin was added to each 1 ml of blood to prevent coagulation.

APPENDIX Heparin 2 mg heparin was dissolved in 0.9 % NaCl (10 ml). 200 µl of heparin was added to each 1 ml of blood to prevent coagulation. APPENDIX 1 Preparation of reagents 1.1. Preparation of dosing solution Nonylphenol 15 mg of Nonylphenol was dissolved in olive oil (10 ml) and used as stock solution. The stock solution was serially diluted

More information

condition. Left panel, the HCT-116 cells were lysed with RIPA buffer containing 0.1%

condition. Left panel, the HCT-116 cells were lysed with RIPA buffer containing 0.1% FIGURE LEGENDS Supplementary Fig 1 (A) sumoylation pattern detected under denaturing condition. Left panel, the HCT-116 cells were lysed with RIPA buffer containing 0.1% SDS in the presence and absence

More information

General Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry:

General Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry: General Laboratory methods Plasma analysis: Plasma insulin (Mercodia, Sweden), leptin (duoset, R&D Systems Europe, Abingdon, United Kingdom), IL-6, TNFα and adiponectin levels (Quantikine kits, R&D Systems

More information

Protein MultiColor Stable, Low Range

Protein MultiColor Stable, Low Range Product Name: DynaMarker Protein MultiColor Stable, Low Range Code No: DM670L Lot No: ******* Size: 200 μl x 3 (DM670 x 3) (120 mini-gel lanes) Storage: 4 C Stability: 12 months at 4 C Storage Buffer:

More information

Early cell death (FGF) B No RunX transcription factor produced Yes No differentiation

Early cell death (FGF) B No RunX transcription factor produced Yes No differentiation Solution Key - Practice Questions Question 1 a) A recent publication has shown that the fat stem cells (FSC) can act as bone stem cells to repair cavities in the skull, when transplanted into immuno-compromised

More information

ulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236

ulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236 Subject Index Actin cellular forms 48, 49 epidermal growth factor, cytoskeletal change induction in mucosal repair 22, 23 wound repair 64, 65 polyamine effects on cytoskeleton 49 51 S-Adenosylmethionine

More information

Supplementary material. Supplementary Figure legends

Supplementary material. Supplementary Figure legends Supplementary material Supplementary Figure legends Supplementary Figure 1: Senescence-associated proliferation stop in response to oncogenic N-RAS expression Proliferation of NHEM cells without (ctrl.)

More information

Chapt 15: Molecular Genetics of Cell Cycle and Cancer

Chapt 15: Molecular Genetics of Cell Cycle and Cancer Chapt 15: Molecular Genetics of Cell Cycle and Cancer Student Learning Outcomes: Describe the cell cycle: steps taken by a cell to duplicate itself = cell division; Interphase (G1, S and G2), Mitosis.

More information

EPIGENTEK. EpiQuik Global Acetyl Histone H3K27 Quantification Kit (Colorimetric) Base Catalog # P-4059 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

EPIGENTEK. EpiQuik Global Acetyl Histone H3K27 Quantification Kit (Colorimetric) Base Catalog # P-4059 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE EpiQuik Global Acetyl Histone H3K27 Quantification Kit (Colorimetric) Base Catalog # P-4059 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Global Acetyl Histone H3K27 Quantification Kit (Colorimetric)

More information

Chapter-IV. Geraniol attenuates phorbol ester-induced inflammatory responses in mouse skin: possible role of p38 MAP Kinase and NF-kB

Chapter-IV. Geraniol attenuates phorbol ester-induced inflammatory responses in mouse skin: possible role of p38 MAP Kinase and NF-kB attenuates phorbol ester-induced inflammatory responses in mouse skin: possible role of p38 MAP Kinase and NF-kB Introduction Dietary natural products have shown protection against various degenerative

More information

Expression and clinical significance of ADAM17 protein in esophageal squamous cell carcinoma

Expression and clinical significance of ADAM17 protein in esophageal squamous cell carcinoma Expression and clinical significance of ADAM17 protein in esophageal squamous cell carcinoma H.B. Liu, Y. Zhu, Q.C. Yang, Y. Shen, X.J. Zhang and H. Chen Department of Pathology First People s Hospital

More information

INTRODUCTION. Induction of Monocyte Chemoattractant Protein-1 (MCP-1) Expression by Angiotensin II (AngII) in the Pancreatic Islets and Beta Cells

INTRODUCTION. Induction of Monocyte Chemoattractant Protein-1 (MCP-1) Expression by Angiotensin II (AngII) in the Pancreatic Islets and Beta Cells Induction of Monocyte Chemoattractant Protein-1 (MCP-1) Expression by Angiotensin II (AngII) in the Pancreatic Islets and Beta Cells Galina Chipitsyna, Qiaoke Gong, Chance F. Gray et al. Endocrinology,

More information

Protocol for Western Blo

Protocol for Western Blo Protocol for Western Blo ng SDS-PAGE separa on 1. Make appropriate percentage of separa on gel according to the MW of target proteins. Related recommenda ons and rou ne recipes of separa on/stacking gels

More information

UNC-Duke Biology Course for Residents Fall Cell Cycle Effects of Radiation

UNC-Duke Biology Course for Residents Fall Cell Cycle Effects of Radiation UNC-Duke Biology Course for Residents Fall 2018 1 Cell Cycle: Sequence of changes in a cell starting with the moment the cell is created by cell division, continuing through the doubling of the DNA and

More information

(A) SW480, DLD1, RKO and HCT116 cells were treated with DMSO or XAV939 (5 µm)

(A) SW480, DLD1, RKO and HCT116 cells were treated with DMSO or XAV939 (5 µm) Supplementary Figure Legends Figure S1. Tankyrase inhibition suppresses cell proliferation in an axin/β-catenin independent manner. (A) SW480, DLD1, RKO and HCT116 cells were treated with DMSO or XAV939

More information

supplementary information

supplementary information DOI: 10.1038/ncb1875 Figure S1 (a) The 79 surgical specimens from NSCLC patients were analysed by immunohistochemistry with an anti-p53 antibody and control serum (data not shown). The normal bronchi served

More information

TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer

TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer Supplementary Information TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer Yabing Mu, Reshma Sundar, Noopur Thakur, Maria Ekman, Shyam Kumar Gudey, Mariya

More information

Intracellular MHC class II molecules promote TLR-triggered innate. immune responses by maintaining Btk activation

Intracellular MHC class II molecules promote TLR-triggered innate. immune responses by maintaining Btk activation Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining Btk activation Xingguang Liu, Zhenzhen Zhan, Dong Li, Li Xu, Feng Ma, Peng Zhang, Hangping Yao and Xuetao

More information

Islet viability assay and Glucose Stimulated Insulin Secretion assay RT-PCR and Western Blot

Islet viability assay and Glucose Stimulated Insulin Secretion assay RT-PCR and Western Blot Islet viability assay and Glucose Stimulated Insulin Secretion assay Islet cell viability was determined by colorimetric (3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide assay using CellTiter

More information

Supplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of

Supplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of Supplemental Figure Legends Supplemental Figure 1. Western blot analysis indicated that was detected in the fractions of plasma membrane and cytosol but not in nuclear fraction isolated from Pkd1 null

More information

Supplemental Information

Supplemental Information Electronic Supplementary Material (ESI) for Food & Function. This journal is The Royal Society of Chemistry 2016 Supplemental Information Supplementary Materials and Methods Materials Assay kits of total

More information

Supporting Online Material Material and Methods References Supplemental Figures S1, S2, and S3

Supporting Online Material Material and Methods References Supplemental Figures S1, S2, and S3 Supporting Online Material Material and Methods References Supplemental Figures S1, S2, and S3 Sarbassov et al. 1 Material and Methods Materials Reagents were obtained from the following sources: protein

More information

Correspondence to: Jun-nian Zheng, * These authors contributed equally to this paper.

Correspondence to: Jun-nian Zheng,   * These authors contributed equally to this paper. Decreased expression of CHIP leads to increased angiogenesis via VEGF-VEGFR2 pathway and poor prognosis in human renal cell carcinoma Chao Sun 1, 2, 4, *, Hai-long Li 1, 2, *, Hai-rong Chen 6, *, Mei-lin

More information

Supplementary Figure 1. MAT IIα is Acetylated at Lysine 81.

Supplementary Figure 1. MAT IIα is Acetylated at Lysine 81. IP: Flag a Mascot PTM Modified Mass Error Position Gene Names Score Score Sequence m/z [ppm] 81 MAT2A;AMS2;MATA2 35.6 137.28 _AAVDYQK(ac)VVR_ 595.83-2.28 b Pre-immu After-immu Flag- WT K81R WT K81R / Flag

More information

NF-κB p65 (Phospho-Thr254)

NF-κB p65 (Phospho-Thr254) Assay Biotechnology Company www.assaybiotech.com Tel: 1-877-883-7988 Fax: 1-877-610-9758 NF-κB p65 (Phospho-Thr254) Colorimetric Cell-Based ELISA Kit Catalog #: OKAG02015 Please read the provided manual

More information

Supplementary Figure 1 Role of Raf-1 in TLR2-Dectin-1-mediated cytokine expression

Supplementary Figure 1 Role of Raf-1 in TLR2-Dectin-1-mediated cytokine expression Supplementary Figure 1 Supplementary Figure 1 Role of Raf-1 in TLR2-Dectin-1-mediated cytokine expression. Quantitative real-time PCR of indicated mrnas in DCs stimulated with TLR2-Dectin-1 agonist zymosan

More information

Supplementary Figure 1

Supplementary Figure 1 Supplementary Figure 1 6 HE-50 HE-116 E-1 HE-108 Supplementary Figure 1. Targeted drug response curves of endometrial cancer cells. Endometrial cancer cell lines were incubated with serial dilutions of

More information

SUPPLEMENTAL MATERIAL. Supplementary Methods

SUPPLEMENTAL MATERIAL. Supplementary Methods SUPPLEMENTAL MATERIAL Supplementary Methods Culture of cardiomyocytes, fibroblasts and cardiac microvascular endothelial cells The isolation and culturing of neonatal rat ventricular cardiomyocytes was

More information

MEK1 Assay Kit 1 Catalog # Lot # 16875

MEK1 Assay Kit 1 Catalog # Lot # 16875 MEK1 Assay Kit 1 Kit Components Assay Dilution Buffer (ADB), Catalog # 20-108. Three vials, each containing 1.0ml of assay dilution buffer (20mM MOPS, ph 7.2, 25mM ß-glycerol phosphate, 5mM EGTA, 1mM sodium

More information

supplementary information

supplementary information Figure S1 Nucleotide binding status of RagA mutants. Wild type and mutant forms of MycRagA was transfected into HEK293 cells and the transfected cells were labeled with 32 Pphosphate. MycRagA was immunoprecipitated

More information

Convergent and Divergent Mechanisms in Aging and Cancer

Convergent and Divergent Mechanisms in Aging and Cancer Convergent and Divergent Mechanisms in Aging and Cancer Mariana S. De Lorenzo, PhD Department of Cell Biology & Molecular Medicine delorems@umdnj.edu LEARNING OBJECTIVES 1. To identify convergent and divergent

More information

Supplemental Data Macrophage Migration Inhibitory Factor MIF Interferes with the Rb-E2F Pathway

Supplemental Data Macrophage Migration Inhibitory Factor MIF Interferes with the Rb-E2F Pathway Supplemental Data Macrophage Migration Inhibitory Factor MIF Interferes with the Rb-E2F Pathway S1 Oleksi Petrenko and Ute M. Moll Figure S1. MIF-Deficient Cells Have Reduced Transforming Ability (A) Soft

More information

PI3K Background. The SignalRx R & D pipeline is shown below followed by a brief description of each program:

PI3K Background. The SignalRx R & D pipeline is shown below followed by a brief description of each program: PI3K Background The phosphatidylinositol 3-kinase (PI3K) pathway is a key cell signaling node whose dysregulation commonly results in the transformation of normal cells into cancer cells. The role of PI3K

More information

Supplementary Figure 1:

Supplementary Figure 1: Supplementary Figure 1: (A) Whole aortic cross-sections stained with Hematoxylin and Eosin (H&E), 7 days after porcine-pancreatic-elastase (PPE)-induced AAA compared to untreated, healthy control aortas

More information

Supplementary Figure 1: Neuregulin 1 increases the growth of mammary organoids compared to EGF. (a) Mammary epithelial cells were freshly isolated,

Supplementary Figure 1: Neuregulin 1 increases the growth of mammary organoids compared to EGF. (a) Mammary epithelial cells were freshly isolated, 1 2 3 4 5 6 7 8 9 10 Supplementary Figure 1: Neuregulin 1 increases the growth of mammary organoids compared to EGF. (a) Mammary epithelial cells were freshly isolated, embedded in matrigel and exposed

More information

Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer

Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Epstein-Barr virus driven promoter hypermethylated genes in gastric cancer J Yu *, KF To, QY Liang K e y M e s s a g e s 1. Somatostatin receptor 1

More information

Supplementary Figure 1 CD4 + T cells from PKC-θ null mice are defective in NF-κB activation during T cell receptor signaling. CD4 + T cells were

Supplementary Figure 1 CD4 + T cells from PKC-θ null mice are defective in NF-κB activation during T cell receptor signaling. CD4 + T cells were Supplementary Figure 1 CD4 + T cells from PKC-θ null mice are defective in NF-κB activation during T cell receptor signaling. CD4 + T cells were isolated from wild type (PKC-θ- WT) or PKC-θ null (PKC-θ-KO)

More information

Tumour growth environment modulates Chk1 signalling pathways and sensitivity to Chk1 inhibition

Tumour growth environment modulates Chk1 signalling pathways and sensitivity to Chk1 inhibition Tumour growth environment modulates Chk1 signalling pathways and sensitivity to Chk1 inhibition Andrew J Massey Supplementary Information Supplementary Figure S1. Related to Fig. 1. (a) HT29 or U2OS cells

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION DOI: 10.1038/ncb3076 Supplementary Figure 1 btrcp targets Cep68 for degradation during mitosis. a) Cep68 immunofluorescence in interphase and metaphase. U-2OS cells were transfected with control sirna

More information

Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-

Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC- Supplemental material and methods Reagents. Hydralazine was purchased from Sigma-Aldrich. Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC- 133, human thyroid medullary

More information

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland

PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland AD Award Number: W81XWH-12-1-0248 TITLE: Targeted Inhibition of Tyrosine Kinase-Mediated Epigenetic Alterations to Prevent Resurgence of Castration-Resistant Prostate Cancer PRINCIPAL INVESTIGATOR: Dr.

More information

Impact factor: Reporter:4A1H0019 Chen Zi Hao 4A1H0023 Huang Wan ting 4A1H0039 Sue Yi Zhu 4A1H0070 Lin Guan cheng 4A1H0077 Chen Bo xuan

Impact factor: Reporter:4A1H0019 Chen Zi Hao 4A1H0023 Huang Wan ting 4A1H0039 Sue Yi Zhu 4A1H0070 Lin Guan cheng 4A1H0077 Chen Bo xuan Curcumin Protects Neonatal Rat Cardiomyocytes against High Glucose-Induced Apoptosis via PI3K/Akt Signalling Pathway Wei Yu,1,2 Wenliang Zha,1 Zhiqiang Ke,1 Qing Min,2 Cairong Li,1 Huirong Sun,3 and Chao

More information

Hunk is required for HER2/neu-induced mammary tumorigenesis

Hunk is required for HER2/neu-induced mammary tumorigenesis Research article Hunk is required for HER2/neu-induced mammary tumorigenesis Elizabeth S. Yeh, 1 Thomas W. Yang, 1 Jason J. Jung, 1 Heather P. Gardner, 1 Robert D. Cardiff, 2 and Lewis A. Chodosh 1 1 Department

More information

Supplementary Materials and Methods

Supplementary Materials and Methods Supplementary Materials and Methods Immunoblotting Immunoblot analysis was performed as described previously (1). Due to high-molecular weight of MUC4 (~ 950 kda) and MUC1 (~ 250 kda) proteins, electrophoresis

More information

A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation

A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation Carcinogenesis vol.34 no.10 pp.2350 2360, 2013 doi:10.1093/carcin/bgt224 Advance Access publication June 19, 2013 A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB

More information

Cells and reagents. Synaptopodin knockdown (1) and dynamin knockdown (2)

Cells and reagents. Synaptopodin knockdown (1) and dynamin knockdown (2) Supplemental Methods Cells and reagents. Synaptopodin knockdown (1) and dynamin knockdown (2) podocytes were cultured as described previously. Staurosporine, angiotensin II and actinomycin D were all obtained

More information

TITLE: The Role of hcdc4 as a Tumor Suppressor Gene in Genomic Instability Underlying Prostate Cancer

TITLE: The Role of hcdc4 as a Tumor Suppressor Gene in Genomic Instability Underlying Prostate Cancer AD Award Number: TITLE: The Role of hcdc4 as a Tumor Suppressor Gene in Genomic Instability Underlying Prostate Cancer PRINCIPAL INVESTIGATOR: Audrey van Drogen, Ph.D. CONTRACTING ORGANIZATION: Sidney

More information